Clinical Trial Update: Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial safety update for lapaquistat acetate in subjects with hypercholesterolemia has been completed, outlining safety findings from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED